Jane Street
RPRX

Jane Street’s Repros Therapeutics Inc. RPRX Stock Holding History

Jane Street’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-53,423
Closed -$382K – 4723
2015
Q2 		$382K Buy
+53,423
New +$416K ﹤0.01% 2565
2014
Q3 		– Sell
-13,408
Closed -$232K – 3608
2014
Q2 		$232K Sell
13,408
-37,304
-74% -$608K ﹤0.01% 2077
2014
Q1 		$900K Buy
+50,712
New +$981K 0.01% 1044
2013
Q4 		– Sell
-23,931
Closed -$641K – 3454
2013
Q3 		$641K Buy
+23,931
New +$513K 0.01% 1526

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return

Jane Street's RPRX Position: Q3 2015 in Review

Jane Street sold out of Repros Therapeutics Inc. (RPRX) in Q3 2015, closing a stake of 53,423 shares — an estimated $382K sold.

Jane Street first reported a position in RPRX in Q3 2013 and held it in 4 quarters. The position peaked at $900K in Q1 2014. 58 funds tracked by Wall St. Rank hold RPRX as of Q3 2015.

  • Jane Street reported no remaining Repros Therapeutics Inc. position as of Q3 2015 after selling out during the quarter.
  • Jane Street sold 53,423 Repros Therapeutics Inc. shares in Q3 2015, an estimated $382K.
  • Jane Street first reported a position in Repros Therapeutics Inc. in Q3 2013 and held it in 4 quarters.
  • Jane Street's Repros Therapeutics Inc. position peaked at $900K in Q1 2014.
  • 58 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q3 2015.

Based on Jane Street's 13F filing for Q3 2015, filed 16 Nov 2015.